tiprankstipranks
Barinthus Biotherapeutics (BRNS)
NASDAQ:BRNS
US Market
BRNS
Barinthus Biotherapeutics
RESEARCH TOOLSreports

Barinthus Biotherapeutics (BRNS) Cash flow

108 Followers

Barinthus Biotherapeutics Cash Flow

BRNS's free cash flow for Q4 2025 was $-4.20M. For the 2025 fiscal year, BRNS's free cash flow was decreased by $-18.18M and operating cash flow was $-4.20M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -47.98M$ -28.94M$ -50.92M$ -14.43M$ -32.58M
Investing Cash Flow
$ 416.00K$ -892.00K$ -5.41M$ -5.75M$ -12.91M
Financing Cash Flow
$ 2.00K$ 2.16M$ 1.87M$ 325.00K$ 222.74M
End Cash Position
$ 71.85M$ 112.40M$ 142.09M$ 194.38M$ 214.05M
Free Cash Flow
$ -48.02M$ -29.83M$ -56.34M$ -20.57M$ -33.73M
Currency in USD

Barinthus Biotherapeutics Cash Flow